home / stock / atos / atos news


ATOS News and Press, Atossa Therapeutics Inc.

Stock Information

Company Name: Atossa Therapeutics Inc.
Stock Symbol: ATOS
Market: NASDAQ
Website: atossatherapeutics.com

Menu

ATOS ATOS Quote ATOS Short ATOS News ATOS Articles ATOS Message Board
Get ATOS Alerts

News, Short Squeeze, Breakout and More Instantly...

ATOS - 3 Dirt-Cheap Drug Developers With Blockbuster Potential

2024-07-11 07:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the more exciting yet admittedly risky types of investing is buying into cheap drug developer stocks early in their company life cycle. That’s because the world of drug developmen...

ATOS - Executive reshuffles: NIO, Pfizer and Spirit Airlines in focus

2024-07-05 13:04:53 ET More on Nio, Pfizer. NIO: It's Getting Interesting NIO Stock: Slam The Brakes On This No-Moat EV Operator Pfizer: It Could Be A Bargain Chinese EV makers slapped with 'countervailing' EU tariffs Biggest stock movers today: Crypt...

ATOS - 3 Penny Stock Moonshots with 300%+ Upside Potential by 2025

2024-07-03 09:45:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips By now, you’re well aware of the dangers of trading penny stocks with upside. But as a reminder, not only will you find a disclaimer at the tail-end of this article about penny stock...

ATOS - Atossa Therapeutics appoints Heather Rees as chief financial officer

2024-07-02 16:23:54 ET More on Atossa Therapeutics Atossa stock climbs 11% on breast cancer drug data ATOS, SMR and EIGR are among pre market gainers Seeking Alpha’s Quant Rating on Atossa Therapeutics Historical earnings data for Atossa Therapeutics ...

ATOS - Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer

SEATTLE, July 02, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced the appointment of Heather Rees as the Company’s new Chief Financial Officer (CFO). Ms. Rees most recently served as Atossa’s ...

ATOS - Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer

SEATTLE, June 28, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced protocol changes in the previously initiated study to evaluate Atossa’s proprietary (Z)-endoxifen in combination with abemaciclib (VER...

ATOS - Atossa Set to Join Russell 3000® Index Effective June 28, 2024

SEATTLE, June 17, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced its expected upcoming inclusion in the Russell 3000 ® Index, according to preliminary Russell reconstruction information posted on ...

ATOS - Sidoti Events, LLC's Virtual June Small-Cap Conference

NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to ...

ATOS - Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar

2024-06-07 07:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a meme frenzy, any positive news related to a company has a magnified impact on the stock price. In the euphoria of 2021, companies with ambitious growth plans skyrocketed. The markets didn&...

ATOS - Atossa to Present at the Sidoti Small-Cap Investor Conference

SEATTLE, June 05, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that the Company will present at the Sidoti Small-Cap Investor Conference being held June 12-13, 2024. The presentation by Steven Quay, M.D....

Next 10